Board of Directors

Owen Garrick, MD MBA

President/CEO, Bridge Clinical Research

Owen Garrick, MD MBA is President & CEO of Bridge Clinical Research (BCR), a global clinical research and health communications firm focused on drug development, scientific advancement and patient engagement. It is active in five therapeutic areas: anti-infectives, autoimmune, cardiovascular disease, endocrinology and oncology. Dr. Garrickleads the Clinical Trials, Research Analytics, Health Services Research and Healthcare Communications business units. He has helped launch multiple collaborative efforts in advancing precision medicine research. He serves as an advisor to the Stanford Precision Health for Ethnic and Racial Equity Center (SPHERE) which is one of five NIH centers focused on precision-medicine tools to improve the health of underserved ethnic and racial groups. Dr. Garrick is a Stanford co-investigator for research using Color Genomics tool kits exploring patient decisions with genetic testing and is a Stanford sub-awardee for a project specifically focused on the willingness of patients with sickle cell disease to participate in precision medicine research.

Dr. Garrick is a nationally recognized leader in research and research ethics. He is a member of the National Genome Research Institute’s (NHGRI) Genomic Education of Healthcare Professionals Partnership. He was appointed to a term as a member of the Department of Health and Human Services Secretary’s Advisory Council on Human Research Protections (SACHRP) from 2012-2016 where he co-authored industry advisory documents around biospecimen data security and patient engagement in research. Dr. Garrick currently serves on the Executive Committee of Professional Responsibility in Medicine & Research (PRIMR) and was formerly a member of Quorum Review’s IRB. Dr. Garrick earned his MD from Yale School of Medicine and his MBA from Wharton School of Business. He holds an AB in Psychology from Princeton University.